California State Board of Pharmacy Intends to Enter the Food and Drug Administration’s Memorandum of Understanding Addressing Certain Distributions of Compounded Human Drug Products

By Steven Funk On April 29-30, 2021, the California Board of Pharmacy (Board) held a meeting [Agenda Item XI(b–c)], where the Board expressed its intention to sign the Food and Drug Administration’s (FDA) Memorandum of Understanding Addressing Certain Distributions of Continue reading

New Laws Regarding Security Prescription Form Requirements and CURES Reporting

By Anna Schwartz On January 1, 2021, two laws imposing security prescription requirements on pharmacists and other licenses went into effect after nearly three years in the making. In September 2018, California first enacted AB 1753 (Low) (Chapter 479, Statutes Continue reading

Board of Pharmacy Fines and Disciplines AmerisourceBergen for “Excessive” Opioid Shipments

By Stephanie Mendivil On January 22, 2020, the Board adopted a Stipulated Settlement and Disciplinary Order which fined AmerisourceBergen Drug Corporation for shipping “excessive” amounts of opioids and other controlled substances to pharmacies across California. The Board also publicly reproved Continue reading